Cargando…
TMBIM1 promotes proliferation and attenuates apoptosis in glioblastoma cells by targeting the p38 MAPK signalling pathway
Glioblastoma multiforme (GBM) is the most common and most fatal primary malignant brain tumour in adults. The average survival time of patients after diagnosis is only 12–15 months. And its characteristics of excessive proliferation and apoptosis evasion play a crucial role in the poor prognosis of...
Autores principales: | Cai, Jiayang, Gao, Lun, Wang, Yixuan, Li, Yong, Ye, Zhang, Tong, Shiao, Yan, Tengfeng, sun, Qian, Xu, Yang, Jiang, Hongxiang, Zhang, Si, Zhao, Linyao, Yang, Ji'an, Chen, Qianxue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920937/ https://www.ncbi.nlm.nih.gov/pubmed/35279540 http://dx.doi.org/10.1016/j.tranon.2022.101391 |
Ejemplares similares
-
BIRB796, an Inhibitor of p38 Mitogen-Activated Protein
Kinase, Inhibits Proliferation and Invasion in Glioblastoma Cells
por: Zhao, Linyao, et al.
Publicado: (2021) -
RND2 attenuates apoptosis and autophagy in glioblastoma cells by targeting the p38 MAPK signalling pathway
por: Xu, Yang, et al.
Publicado: (2020) -
Betulinic acid self-assembled nanoparticles for effective treatment of glioblastoma
por: Li, Yong, et al.
Publicado: (2022) -
The New PI3K/mTOR Inhibitor GNE-477 Inhibits the Malignant Behavior of Human Glioblastoma Cells
por: Wang, Yixuan, et al.
Publicado: (2021) -
Fatostatin induces ferroptosis through inhibition of the AKT/mTORC1/GPX4 signaling pathway in glioblastoma
por: Cai, Jiayang, et al.
Publicado: (2023)